Alibaba vs JD.com
BABA and JD side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BABA and JD compare
JD.com grew revenue faster over the last twelve months (13.0% versus 2.7% for Alibaba).
JD.com scores higher on the StockData Score (7 against 6 for Alibaba), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BABA | JD |
|---|---|---|
| Size and price | ||
| Share price | $98.04 | $25.68 |
| Change, 1 year | −45.5% | −25.3% |
| Change, 5 years | −38.2% | −66.9% |
| Beta (5Y) | 0.93 | 0.81 |
| Employees | 4.0M | 100K |
| StockData Score | ||
| Total score | 6 | 7 (better) |
| Valuation score | 0 | 0 |
| Growth score | 1 | 3 (better) |
| Performance score | 3 (better) | 1 |
| Health score | 2 | 3 (better) |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | 2.7% | 13.0% (better) |
| Revenue growth, 5Y average | 7.4% | 11.9% (better) |
| Net income growth (TTM) | −20.4% | – |
| EPS growth (TTM) | −17.9% (better) | −52.0% |
| EPS growth, 5Y average | −4.3% (better) | −16.4% |
| Profitability | ||
| Gross margin | 39.8% (better) | 16.0% |
| Operating margin | 4.9% (better) | 0.21% |
| Net margin | 10.1% | – |
| FCF margin | – | 0.85% |
| Return on equity | 10.0% | – |
| Return on invested capital | 5.5% | 12.8% (better) |
| Financial health | ||
| Debt / equity | – | 0.05 |
| Net debt / EBITDA | – | −16.13 |
| Interest coverage | 5.1× (better) | 1.0× |
| Current ratio | 1.28 (better) | 1.22 |
| Piotroski F-score | 5 | – |
| Dividends and buybacks | ||
| Payout ratio | 32.6% | – |
| Ownership | ||
| Held by institutions | 1.3% | 7.2% |
| Held by insiders | 0.96% | 13.2% |
| Insider net buying, 12 months | −$48.2M | – |
| Superinvestors holding | 6 (better) | 3 |
Go deeper
- BABA stock overview
- BABA income statement
- BABA valuation and score
- JD stock overview
- JD income statement
- JD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.